NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops show promise for healing corneal damage
Disease control CompletedThis study tested an experimental eye drop called CSB-001 in 131 people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop ulcers. Participants used the drops four times daily for 8 weeks. The goal was to see if the drops could fully he…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1, PHASE2 • Sponsor: Claris Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New eye drop shows promise for rare corneal disease
Disease control CompletedThis early-stage trial tested an experimental eye drop called STSP-0902 in 82 healthy volunteers to see if it is safe and how the body processes it. The study involved single and multiple doses, with some participants getting a placebo. The goal is to eventually treat neurotrophi…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
OXERVATE eye drops show promise for Long-Term corneal healing in rare eye disease
Disease control CompletedThis study followed 24 people with stage 1 neurotrophic keratitis, a rare eye condition that can damage the cornea, who had previously used OXERVATE eye drops in an earlier study. Researchers checked if the cornea stayed healed up to 30 months after treatment. The goal was to see…
Matched conditions: NEUROTROPHIC KERATITIS
Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New eye drop shows promise for rare corneal disease
Disease control CompletedThis study tested an eye drop called OXERVATE in 37 adults with stage 1 neurotrophic keratitis, a condition where the cornea loses feeling and doesn't heal properly. The treatment was given for 8 weeks, and patients were followed for 24 weeks to see if the cornea healed safely. T…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE4 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC